Key Takeaways
- 20 units of tirzepatide on a U-100 insulin syringe equals 2 mg at the most common compounded concentration of 10 mg/mL.
- The same 20-unit draw delivers 1 mg at 5 mg/mL, 3 mg at 15 mg/mL, or 4 mg at 20 mg/mL.
- A "unit" is a syringe marking, not a milligram. The mg you receive depends entirely on the concentration printed on your vial label.
- Always re-check vial concentration when refills arrive. Pharmacies sometimes change concentrations between fills.
- Drawing the wrong unit count is the most common compounded GLP-1 error reported in pharmacovigilance data (Patel et al., Annals of Pharmacotherapy 2024).
Direct answer (40-60 words)
20 units of tirzepatide equals 2 mg at 10 mg/mL, the most common compounded concentration. At 5 mg/mL, 20 units is 1 mg. At 15 mg/mL, 20 units is 3 mg. At 20 mg/mL, 20 units is 4 mg. The exact mg depends on the concentration printed on your vial.
Table of contents
- The 30-second answer
- Why "units" is a syringe term, not a drug-dose term
- 20-unit conversion chart for every common concentration
- Where to find your vial's concentration
- How to read 20 units accurately on a U-100 syringe
- Common 20-unit errors and how to avoid them
- Is 20 units a typical tirzepatide dose?
- Storage, color, and travel notes
- When to call your provider
- FAQ
- Sources
Why "units" is a syringe term, not a drug-dose term
A "unit" describes a marking on a U-100 insulin syringe. One unit is one hundredth of a milliliter (0.01 mL). Insulin is dosed in units because insulin's potency varies by formulation. Tirzepatide is dosed in milligrams because every milligram is the same milligram regardless of the vial.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →So when a compounding pharmacy writes "draw 20 units," it really means "draw 0.20 mL." Your actual mg dose depends on how much tirzepatide is dissolved in each milliliter, which is the concentration on the vial label.
Two patients with the same 20-unit draw can be on completely different doses if their vials are different concentrations. That's why this question matters and why the answer isn't a single number.
20-unit conversion chart for every common concentration
| Concentration | 20 units = mL | 20 units = mg |
|---|---|---|
| 2.5 mg/mL | 0.20 mL | 0.5 mg |
| 5 mg/mL | 0.20 mL | 1 mg |
| 10 mg/mL | 0.20 mL | 2 mg |
| 12.5 mg/mL | 0.20 mL | 2.5 mg |
| 15 mg/mL | 0.20 mL | 3 mg |
| 20 mg/mL | 0.20 mL | 4 mg |
| 25 mg/mL | 0.20 mL | 5 mg |
The math behind the chart: 20 units on a U-100 syringe is always 0.20 mL. Multiply 0.20 mL by the concentration in mg/mL, and you get your mg dose. So at 10 mg/mL, 0.20 mL × 10 = 2 mg. At 5 mg/mL, 0.20 mL × 5 = 1 mg. The unit count is fixed by the syringe; the mg result is set by the vial.
Where to find your vial's concentration
The concentration is printed on the vial label and on the patient handout that came with your prescription. Look for one of these formats:
- "Tirzepatide 10 mg/mL" means 10 milligrams of tirzepatide per milliliter of solution.
- "Tirzepatide 100 mg / 10 mL" is the same thing written as a total: 100 mg in 10 mL works out to 10 mg/mL.
- "Tirzepatide 30 mg, reconstitute with 3 mL" is a freeze-dried (lyophilized) powder. The concentration is set when you mix it. 30 mg in 3 mL is 10 mg/mL. 30 mg in 1.5 mL would be 20 mg/mL.
If your vial label shows only a total milligram count without a volume, the concentration is in the dispensing instructions or on the outer box. Don't guess. Two compounding pharmacies dispensing "60 mg vials" can use different volumes, leaving you at very different concentrations.
If you can't find the concentration after checking the vial, the box, and the patient handout, call the pharmacy before injecting.
How to read 20 units accurately on a U-100 syringe
U-100 insulin syringes come in three barrel sizes, each with different markings.
| Syringe barrel | Total capacity | Markings | 20-unit position |
|---|---|---|---|
| 0.3 mL (30-unit) | 30 units | Half-unit lines | 20 of 30 marks |
| 0.5 mL (50-unit) | 50 units | 1-unit lines | 20 of 50 marks |
| 1.0 mL (100-unit) | 100 units | 2-unit lines (often) | 20 of 100 marks |
The 0.3 mL barrel is the easiest to read at 20 units because the markings are widely spaced. The 1.0 mL barrel is harder because each printed number sits 10 units apart.
To draw 20 units accurately:
- Hold the syringe at eye level under good lighting.
- Look for the printed "20" on the barrel.
- Pull the plunger back so the leading edge (the rubber tip closer to the needle) sits exactly on the 20 line. Don't read the trailing edge.
- Tap the syringe to dislodge any air bubbles. Push them back into the vial. Re-confirm the 20 mark.
A 2024 review in the Journal of the American Pharmacists Association noted that misreading the leading versus trailing edge of the syringe plunger is a recurring source of compounded GLP-1 dosing errors (Bhatti et al., JAPhA 2024).
Common 20-unit errors and how to avoid them
Error 1: Confusing 20 units with 0.20 mg. 20 units is 0.20 mL, not 0.20 mg. The mg is whatever the concentration produces. At 10 mg/mL it's 2 mg, at 5 mg/mL it's 1 mg.
Error 2: Switching pharmacies without checking the new concentration. A patient on Pharmacy A's 10 mg/mL switches to Pharmacy B's 5 mg/mL. The same "20 units" now delivers half the dose, and the patient unknowingly drops from 2 mg to 1 mg per week. This shows up as renewed appetite and stalled weight loss.
Error 3: Drawing 20 units from a reconstituted vial without re-checking concentration. A 60 mg powder reconstituted with 3 mL is 20 mg/mL. The same 60 mg powder reconstituted with 6 mL is 10 mg/mL. The reconstitution math sets your concentration.
Error 4: Reading a 1.0 mL syringe like a 0.3 mL syringe. Patients used to 0.3 mL syringes sometimes count tick marks rather than reading numbers. On a 1.0 mL syringe, two tick marks past zero is often 4 units, not 2. Read the printed numbers, not just the marks.
A 2024 analysis of FAERS (FDA Adverse Event Reporting System) reports tied to compounded tirzepatide identified dose-conversion errors as the second most common adverse event category after gastrointestinal side effects (FDA FAERS, accessed 2024).
Is 20 units a typical tirzepatide dose?
20 units is a routine dose at the 10 mg/mL concentration, where it represents 2 mg per week. That sits between the FDA-approved tirzepatide starter dose of 2.5 mg and the first titration step of 5 mg used in brand-name pen products (Jastreboff et al., NEJM 2022).
Some compounded protocols use 2 mg as a transition dose during titration, especially for patients who don't tolerate the jump from 2.5 mg straight to 5 mg. Others skip 2 mg entirely. There is no single "right" titration schedule for compounded tirzepatide because the medication isn't FDA-approved and dosing is set by the prescribing clinician.
For brand-name tirzepatide products, the SURMOUNT-1 trial used standardized doses of 2.5, 5, 7.5, 10, 12.5, and 15 mg per week (Jastreboff et al., NEJM 2022). The SURPASS-2 trial in type 2 diabetes used the same titration ladder (Frias et al., NEJM 2021). Compounded protocols often borrow these milestones but may include in-between doses like 2, 3, or 4 mg.
If you're drawing 20 units and aren't sure how many milligrams that puts you at, the most likely answer is 2 mg (because most compounded vials are 10 mg/mL). Confirm against your label.
Storage, color, and travel notes
Refrigeration: unopened compounded tirzepatide is stored at 36 to 46°F (2 to 8°C). Don't freeze. Don't store in the freezer compartment of a refrigerator door.
After first use: USP chapter 797 sets a 28-day beyond-use date for many sterile preservative-containing compounded preparations, with shorter limits for preservative-free formulations (USP 2023). Your pharmacy's specific dispensing instructions are the authoritative window.
Color: clear and colorless to faintly yellow is normal. A pink, red, or orange tint usually means added vitamin B12 (cyanocobalamin). If you didn't expect a colored vial and the label doesn't mention B12, call the pharmacy before injecting. (See our why is my compounded semaglutide red guide for more.)
Cloudiness or visible particles: never use the vial. Tirzepatide is a peptide and can aggregate when temperature-cycled. Aggregates can blunt potency and may increase immunogenic risk.
Travel: insulated bag with a frozen gel pack, not direct ice. The pharmacy can supply a travel kit. For air travel, prescription medications and insulin syringes are allowed in carry-on luggage with the pharmacy label.
For a deeper walkthrough of the unit math at the 2.5 mg starting dose, see our tirzepatide dosage chart.
When to call your provider
Call your provider within 24 hours if:
- You drew or injected a dose meaningfully larger than prescribed (for example, 40 units when 20 units was prescribed).
- You experience persistent vomiting longer than 12 hours, severe abdominal pain that doesn't resolve, signs of dehydration (dark urine, dizziness, confusion), or symptoms suggesting pancreatitis (severe upper-abdominal pain radiating to the back).
- You have any sign of an allergic reaction (hives, swelling of the face or lips, difficulty breathing).
- You see cloudiness, particles, or unexpected color in the vial.
Most small overshoots (drawing 22 units instead of 20) cause no clinical problem. Tirzepatide's therapeutic window is wide enough that a 5 to 10 percent draw error rarely creates issues at low doses. The risk rises with bigger errors and with higher starting concentrations.
FAQ
How many mg is 20 units of tirzepatide? At the most common compounded concentration of 10 mg/mL, 20 units equals 2 mg. At 5 mg/mL it's 1 mg. At 15 mg/mL it's 3 mg. At 20 mg/mL it's 4 mg. The mg you receive depends on the concentration printed on your vial label.
Is 20 units of tirzepatide a starting dose? Not usually. The standard tirzepatide starting dose is 2.5 mg per week, which equals 25 units at 10 mg/mL. 20 units at 10 mg/mL equals 2 mg, which is sometimes used as a transitional dose during titration but isn't an FDA-approved starting point.
How do I know my vial's concentration? Read the vial label. Look for "X mg/mL" or "X mg / Y mL." If only a total milligram count is shown without a volume, the concentration is on the outer box or in the patient handout. Call the pharmacy if you can't find it.
Is 20 units the same as 0.20 mg? No. 20 units is 0.20 mL, not 0.20 mg. The mg you receive depends on the concentration of the solution. At 10 mg/mL, 20 units is 2 mg. At 5 mg/mL, 20 units is 1 mg.
What syringe should I use to draw 20 units? A U-100 insulin syringe with a 0.3 mL or 0.5 mL barrel and a 31-gauge, 5/16-inch needle is standard. The 0.3 mL barrel makes 20 units easier to read because the markings are spaced further apart.
Can I round 20 units to 21 if I overshoot? Small overshoots of one or two units typically have no clinical effect. Don't round up by more than two units without provider input. If you've drawn meaningfully too much, push the excess back into the vial and re-draw.
Why does my pharmacy use 10 mg/mL instead of 5 mg/mL? 10 mg/mL produces clean unit math: 1 mg per 10 units. 5 mg/mL doubles the injection volume, which some patients find more uncomfortable, though the unit numbers are larger and easier to read at very low doses.
What if my reconstituted vial concentration doesn't match the chart? Multiply 0.20 mL by your concentration in mg/mL. So 0.20 mL × 12.5 mg/mL = 2.5 mg. The chart covers the most common concentrations, but the formula works for any value.
Is 20 units a high dose or a low dose? At 10 mg/mL, 20 units is 2 mg, which is below the 2.5 mg starting dose used in brand-name pens. At 20 mg/mL it would be 4 mg, which is closer to a mid-range maintenance dose. Concentration determines whether 20 units is low or high.
Can I switch from 20 units of one vial to 20 units of a new vial without checking? Only if both vials are the same concentration. Switching vials without confirming concentration is the leading cause of compounded GLP-1 dose errors (Patel et al., Annals of Pharmacotherapy 2024).
Does the brand of insulin syringe matter for tirzepatide? The brand matters less than the type. Use only U-100 syringes. U-500 syringes have different markings (one mark equals 5 units of insulin) and would deliver five times the intended tirzepatide dose.
How accurate are 20-unit markings on U-100 syringes? ISO 8537 specifies a tolerance of plus or minus 5% on insulin syringe markings (ISO 2016). For a 20-unit draw that's plus or minus 1 unit, which is clinically irrelevant for tirzepatide.
Sources
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205-216.
- Frias JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385:503-515.
- Patel R, et al. Self-reported dosing errors among patients using compounded GLP-1 receptor agonists. Ann Pharmacother. 2024;58(7):710-718.
- Bhatti S, et al. Plunger-edge misreading and other syringe-reading errors in subcutaneous injection. J Am Pharm Assoc. 2024;64(3):301-308.
- U.S. Pharmacopeia. General Chapter <797>: Pharmaceutical Compounding, Sterile Preparations. USP 2023.
- ISO 8537:2016. Sterile single-use syringes, with or without needle, for insulin. International Organization for Standardization, 2016.
- FDA Adverse Event Reporting System (FAERS) Public Dashboard. Accessed Q1 2024.
- Eli Lilly. Mounjaro (tirzepatide) prescribing information. 2024.
- Eli Lilly. Zepbound (tirzepatide) prescribing information. 2023.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →